Financials Previsión Sanitaria Nacional Gestión SOCIMI, S.A.
Equities
YPSN
ES0170756037
Diversified REITs
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.8 EUR | 0.00% |
|
-1.25% | -1.86% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 26.38 | 31.39 | 31.38 | 33.14 | 31.38 | 31.39 |
Enterprise Value (EV) 1 | 32.78 | 42.59 | 42.48 | 43.91 | 41.2 | 40.48 |
P/E ratio | 61.5 x | 54.6 x | 61.2 x | 82.4 x | 48.4 x | 37.3 x |
Yield | - | 1.47% | 1.39% | 1.06% | 1.74% | 2.17% |
Capitalization / Revenue | 16 x | 16 x | 16 x | 18.7 x | 15.2 x | 13.5 x |
EV / Revenue | 19.8 x | 21.7 x | 21.6 x | 24.8 x | 19.9 x | 17.4 x |
EV / EBITDA | 37.4 x | 36.8 x | 36.8 x | 46 x | 32.1 x | 25.3 x |
EV / FCF | 84.9 x | 141 x | -22.8 x | 55.9 x | 47.9 x | 43 x |
FCF Yield | 1.18% | 0.71% | -4.38% | 1.79% | 2.09% | 2.32% |
Price to Book | 1.17 x | 1.4 x | 1.4 x | 1.47 x | 1.38 x | 1.37 x |
Nbr of stocks (in thousands) | 1,969 | 1,950 | 1,949 | 1,949 | 1,949 | 1,949 |
Reference price 2 | 13.40 | 16.10 | 16.10 | 17.00 | 16.10 | 16.10 |
Announcement Date | 11/04/19 | 29/04/20 | 20/04/21 | 22/04/22 | 28/04/23 | 29/02/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 1.653 | 1.963 | 1.965 | 1.773 | 2.067 | 2.331 |
EBITDA 1 | 0.8765 | 1.158 | 1.155 | 0.9547 | 1.282 | 1.6 |
EBIT 1 | 0.5286 | 0.7837 | 0.7804 | 0.5736 | 0.9162 | 1.249 |
Operating Margin | 31.97% | 39.93% | 39.71% | 32.35% | 44.32% | 53.57% |
Earnings before Tax (EBT) 1 | 0.4351 | 0.5883 | 0.5393 | 0.4169 | 0.6608 | 0.8743 |
Net income 1 | 0.4265 | 0.5753 | 0.5128 | 0.4024 | 0.6478 | 0.8409 |
Net margin | 25.79% | 29.31% | 26.09% | 22.7% | 31.33% | 36.07% |
EPS 2 | 0.2178 | 0.2951 | 0.2631 | 0.2064 | 0.3323 | 0.4317 |
Free Cash Flow 1 | 0.3859 | 0.303 | -1.861 | 0.7861 | 0.8607 | 0.9411 |
FCF margin | 23.34% | 15.44% | -94.7% | 44.34% | 41.63% | 40.37% |
FCF Conversion (EBITDA) | 44.03% | 26.16% | - | 82.34% | 67.14% | 58.81% |
FCF Conversion (Net income) | 90.48% | 52.66% | - | 195.35% | 132.87% | 111.91% |
Dividend per Share | - | 0.2360 | 0.2236 | 0.1800 | 0.2801 | 0.3501 |
Announcement Date | 11/04/19 | 29/04/20 | 20/04/21 | 22/04/22 | 28/04/23 | 29/02/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 6.39 | 11.2 | 11.1 | 10.8 | 9.81 | 9.09 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 7.292 x | 9.672 x | 9.618 x | 11.29 x | 7.653 x | 5.683 x |
Free Cash Flow 1 | 0.39 | 0.3 | -1.86 | 0.79 | 0.86 | 0.94 |
ROE (net income / shareholders' equity) | 1.91% | 2.57% | 2.28% | 1.79% | 2.86% | 3.68% |
ROA (Net income/ Total Assets) | 1.26% | 1.53% | 1.42% | 1.05% | 1.7% | 2.35% |
Assets 1 | 33.98 | 37.7 | 36.14 | 38.36 | 38 | 35.74 |
Book Value Per Share 2 | 11.40 | 11.50 | 11.50 | 11.60 | 11.70 | 11.80 |
Cash Flow per Share 2 | 0.3400 | 0.1100 | 0.1600 | 0.0800 | 0.1400 | 0.2300 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 11/04/19 | 29/04/20 | 20/04/21 | 22/04/22 | 28/04/23 | 29/02/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-1.86% | 33.32M | |
-15.07% | 12.04B | |
-18.35% | 7.19B | |
-9.48% | 6.06B | |
-12.50% | 5.25B | |
+3.90% | 4.93B | |
+9.51% | 4.91B | |
-12.20% | 4.88B | |
-14.18% | 4.16B | |
-3.22% | 3.51B |
- Stock Market
- Equities
- YPSN Stock
- Financials Previsión Sanitaria Nacional Gestión SOCIMI, S.A.